Comparing MTA, Emdogain and Human Biological Membrane As A Pulpotomy Agents in Permanent Teeth with Symptoms of Irreversible Pulpitis
- Registration Number
- CTRI/2024/02/062861
- Lead Sponsor
- Zoya Kidwai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
IClinical inclusion criteria:
1.Patients with in range of 18 to 45 years of age.
2.Patients presented with deep carious lesions including the first and second permanent molars.
3.No evidence of any clinical pathology · no mobility and had no tenderness to percussion.
II Radiographic inclusion criteria:
1.Pre-operative radiographs with no evidence of external or internal root resorption.
2. Absence of furcal radiolucency.
3. Absence of periapical radiolucency or widened periodontal ligament space
4.No more than one-third root resorption detected.
1. Patient with systemic diseases like diabetes mellitus, hypertension, hepatitis, human immunodeficiency virus, bone disorders, autoimmune disorders.
2. Patient with Periodontally compromised teeth.
3. Pregnant Females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Check For Vitality Of the Tooth With No Clinical Signs Of Pain and Sensitivity After Using MTA, Emdogain Gel And Human Amniotic Membrane As A Pulpotomy AgentsTimepoint: At 1 month,3 months and 6 months
- Secondary Outcome Measures
Name Time Method To Check For Any Radiographical Signs Of Disease Progression like Periapical Lesion Formation Or Periodontal Widening After Using MTA, Emdogain Gel And Human Amniotic Membrane As A Pulpotomy AgentTimepoint: At 1 month,3 months and 6 months